Memorial Sloan Kettering Cancer Center: all 1,959 studies

Page 12 of 20. Open to participants first (325), then studies with results posted, then the rest; newest registration first within each.

• Predicting Effective Therapy in Pancreatic CancerActive, not recruitingNCT03033927
• A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)Active, not recruitingNCT03033914Phase 1/2
• A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk NeuroblastomaCompletedNCT03033303Phase 2
• Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)CompletedNCT03030885Phase 1
• Clinical Trial of Phenformin in Combination With BRAF Inhibitor + MEK Inhibitor for Patients With BRAF-mutated MelanomaCompletedNCT03026517Phase 1
• Study of Cognitive Behavioral Therapy for Insomnia (CBT-I) and Acupuncture for Insomnia and Related Distress Among Cancer CaregiversCompletedNCT03012425Not applicable
• Taxi STEP (Social Networks, Technology, and Exercise Through Pedometers)Active, not recruitingNCT03010163Not applicable
• Mobile Health Device Study for Myeloma PatientsCompletedNCT03006315
• Feasibility Testing of a Novel Endoscope for Reflectance Confocal Microscopy of Normal Oral Tissue In VivoCompletedNCT03004053
• A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder CancerActive, not recruitingNCT02989584Phase 1/2
• PEACE: Comparing Chronic Pain Treatment OptionsActive, not recruitingNCT02979574Not applicable
• Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial ChemoimmunotherapyTerminatedNCT02966730Early Phase 1
• Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal CancerActive, not recruitingNCT02962063Phase 1/2
• Interest and Impact of Skin Cancer Genetic TestingCompletedNCT02941900
• Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to TreatmentActive, not recruitingNCT02932280Phase 1/2
• Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative StudyCompletedNCT02928549
• Adaptation of Skills Training Manuals for Patients Receiving Hematopoietic Stem Cell Transplantation and Their CaregiversCompletedNCT02928185
• Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck CancerActive, not recruitingNCT02923570Phase 2
• Trial of YUMI Uterine ManipulatorCompletedNCT02923544Not applicable
• Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic AdenocarcinomaActive, not recruitingNCT02921022Not applicable
• Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient OutcomesActive, not recruitingNCT02917798
• Informing the Adaptation of a CHW Model to Facilitate Lung Cancer Screening for the Chinese CommunityCompletedNCT02914899Early Phase 1
• Prevalence of Self Reported Lymphedema in Patients With Endometrial CancerCompletedNCT02912767
• A Study to Assess Thymic Function Using PET/CT and MRICompletedNCT02909075
• Beyond Performance Status: Electronic Activity Monitoring to Assess Functional Activity of Patients With Gastrointestinal Malignancy During Chemotherapy.CompletedNCT02909062
• Study of Captisol Enabled Melphalan and Pharmacokinetics for Patients With Multiple Myeloma or Light Chain Amyloidosis That Are Receiving an Autologous Transplant.Active, not recruitingNCT02909036Phase 1
• A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a HerniaCompletedNCT02908061Phase 3
• Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheetCompletedNCT02902107Phase 1
• A Risk Assessment Tool to Increase Statin Use Among High Risk Cancer Survivors: Development and Pilot TestingCompletedNCT02895880
• Study of Abemaciclib in Dedifferentiated LiposarcomaActive, not recruitingNCT02846987Phase 2
• The Patient-Perspective of Complications After Colon and Rectum Surgery: A Qualitative AnalysisCompletedNCT02836535
• Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)CompletedNCT02836522
• Exercise Testing for Early Stage Breast Cancer Patients Receiving Radiation TreatmentCompletedNCT02836093
• Sleep in Hospitalized Children at MSKCCCompletedNCT02836041
• Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate CancerCompletedNCT02833883Phase 1
• Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer MedicationsCompletedNCT02833246Not applicable
• A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With MyelomaCompletedNCT02831686Phase 1
• Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell TransplantWithdrawnNCT02812082Not applicable
• Utility of Intra-operative Image Guidance System for Missing MetastasesCompletedNCT02806037
• T-Cell Therapy for Advanced Breast CancerActive, not recruitingNCT02792114Phase 1
• Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell LymphomasCompletedNCT02783625Phase 1
• Testing Lenvatinib in Patients With Adenoid Cystic CarcinomaActive, not recruitingNCT02780310Phase 2
• A Study to See if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)WithdrawnNCT02772575
• A Clinical Trial of Buparlisib and Ibrutinib in LymphomaCompletedNCT02756247Phase 1
• Developing a New Questionnaire About Patient Expectations of Breast Conserving TherapyCompletedNCT02753673
• Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast CancerActive, not recruitingNCT02750358Phase 2
• Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation After Thoracic SurgeryActive, not recruitingNCT02750319Phase 3
• Anxiety With Cancer in the Elderly (ACE): A Cognitive-behavioral InterventionCompletedNCT02747160Not applicable
• A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian CancerCompletedNCT02737787Phase 1
• Clinician-Patient Communication in Lung Cancer CareActive, not recruitingNCT02732834
• Meaning-Centered Psychotherapy Training for Cancer Care ProvidersActive, not recruitingNCT02730039
• Feasibility and Tolerability of Transcranial Direct Current Stimulation With Concurrent Cognitive TrainingActive, not recruitingNCT02726763Not applicable
• Physician Use of Non-English Language Skills in Cancer CareCompletedNCT02726360
• Cancer Patients Decision Making and Family Communication About Secondary Findings From Tumor Genomic ProfilingActive, not recruitingNCT02713334
• Body Composition and White Adipose Tissue InflammationCompletedNCT02713022
• Experience of Arab American Women With Breast Cancer: In-depth InterviewsCompletedNCT02710058
• Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and SupportCompletedNCT02701829Not applicable
• Electronic Reporting of Symptoms After SurgeryCompletedNCT02700256
• Trial of a Social Marketing Campaign to Increase HPV Vaccination Among Mexican American ChildrenActive, not recruitingNCT02697396
• Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot StudyCompletedNCT02697383Phase 1
• Emotion Regulation Therapy to Address Distress Among CaregiversCompletedNCT02697357
• Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant CancersCompletedNCT02675829Phase 2
• Pilot Trial of Homebound Stem Cell TransplantationActive, not recruitingNCT02671448Not applicable
• Prospective Registry of Multiplex Testing (PROMPT)Active, not recruitingNCT02665195
• Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator PhenotypeActive, not recruitingNCT02658279Not applicable
• Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) MetastasesCompletedNCT02650752Phase 1
• Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk NeuroblastomaCompletedNCT02650648Phase 1
• Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or OlderWithdrawnNCT02647190Phase 1
• A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic CancerCompletedNCT02643498Phase 1
• Study of Enzalutamide With and Without Sorafenib in Advanced Hepatocellular Carcinoma PatientsCompletedNCT02642913Phase 1
• Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural MesotheliomaWithdrawnNCT02639767Phase 1
• DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin LymphomasActive, not recruitingNCT02633111
• Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx CancersWithdrawnNCT02628912
• Assessment for Long-Term Cardiovascular Impairment Associated With Trastuzumab Cardiotoxicity in HER2-Positive Breast Cancer SurvivorsCompletedNCT02615054
• Uptake and Biodistribution of 18F-fluorocholine in Histiocytic Disorders by PET Imaging and Biopsy MeasurementCompletedNCT02608619
• Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)Active, not recruitingNCT02605486Phase 1/2
• Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell TransplantationCompletedNCT02598752
• Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free FlapsCompletedNCT02572869
• Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)Active, not recruitingNCT02570542Phase 2
• Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support SystemCompletedNCT02565017
• Lenalidomide Maintenance in Plasma Cell MyelomaActive, not recruitingNCT02538198Phase 2
• Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission TomographyNo longer availableNCT02531672
• Study of Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes in Women With Non-Metastatic Breast CancerActive, not recruitingNCT02530177
• Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver ResectionActive, not recruitingNCT02523443Phase 3
• Randomized Controlled Trial Examining Health Care Access Interventions for Taxi DriversActive, not recruitingNCT02508363Not applicable
• Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent OsteosarcomaActive, not recruitingNCT02502786Phase 2
• Caregiver Burden Within the Ambulatory Extended Recovery (AXR) Patient PopulationCompletedNCT02501785
• Cyclophosphamide Followed by Intravenous and Intraperitoneal Infusion of Autologous T Cells Genetically Engineered to Secrete IL-12 and to Target the MUC16ecto Antigen in Patients With Recurrent MUC16ecto+ Solid TumorsActive, not recruitingNCT02498912Phase 1
• Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or OlderActive, not recruitingNCT02494882Phase 1
• Dose-Response of Aerobic Training in Women at High-Risk for Development of Breast CancerActive, not recruitingNCT02494869Not applicable
• Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum BiomarkersWithdrawnNCT02465723Not applicable
• Rapid Pancreatic and Ovarian Screening MR Imaging With Motion Corrected T1, T2, and Advanced Diffusion Weighted Imaging for Patients With BRCA Mutation Who Undergo Screening Breast MRIActive, not recruitingNCT02462460
• Identifying Family Members in Need of Support While Caregiving and After LossActive, not recruitingNCT02455505
• Selection of Allogeneic Hematopoietic Cell Donors Based on KIR and HLA GenotypesActive, not recruitingNCT02450708Not applicable
• Respiratory Motion-Corrected Cone-Beam CT and Intratreatment Gating Based on Electromagnetic Transponders to Reduce Target Position Uncertainty in Radiation Treatment of Lung MalignanciesActive, not recruitingNCT02434809Not applicable
• Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor PrimaryActive, not recruitingNCT02429570Not applicable
• Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen MesothelinActive, not recruitingNCT02414269Phase 1/2
• Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast AbnormalitiesCompletedNCT02406274Not applicable
• Determinants of Bladder Cancer Recurrence Study (The DETER Study)Active, not recruitingNCT02400944
• Health Related Quality of Life Following Hepatectomy for Colorectal Liver Metastasis: Global and Disease Specific Changes Over TimeActive, not recruitingNCT02399995

← Memorial Sloan Kettering Cancer Center overview and focus areas